To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2
Clinical trial NCT05200741 · UNKNOWN
Trial details
- NCT number
- NCT05200741
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2024-02-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.